Enzychem Lifesciences Corporation

₩990.00As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:183490Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (13.74%)
Div yield —
ROE (11.81%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.75
PE TTM —
TSR TTM (2.65%)
Mkt cap ₩76.86B
ROIC (7.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,163
17.46%
(56.25%)
Hold 1|12|3|6|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
21.64
24.10
25.49
25.26
10.53%
27.67%
31.21%
24.98%
Revenue₩B
4.720
4.589
4.641
4.765
2.42%
(2.63%)
(2.66%)
(0.67%)
Peers (US$56.66M)
Cap (US$)
PE
49.92M
13.31x
46.63M
2.890x
43.25M
5.361x
Capital
TTM
5Y
10Y
Leveragex
0.813
—
—
EBIT/Intx
1.480
0.786
0.645
Own earn%
221.61
(51.31)
(54.53)
Sh yield%
25.56
25.23
24.64
Owners
Insiders/Inst%
8.08
83.27
Short interest%
2.34
SBC / revenue%
1.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
15–20
$1 testx
0.0
Incr. ROIC%
8